ARVINAS INC (ARVN)

US04335A1051 - Common Stock

22.69  +1.05 (+4.85%)

After market: 22.69 0 (0%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ARVN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 67.09. This target is 195.7% above the current price.
ARVN was analyzed by 26 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ARVN.
In the previous month the buy percentage consensus was at a similar level.
ARVN was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 22.6930.3065.2867.09115.50 - 33.54% 187.70% 195.70% 409.03%
Up and Down Grades
Date Firm Action Rating
2024-11-20 BMO Capital Maintains Outperform -> Outperform
2024-11-18 Stephens & Co. Initiate Overweight
2024-10-31 Oppenheimer Maintains Outperform -> Outperform
2024-10-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-31 Cantor Fitzgerald Reiterate Overweight
2024-07-31 Oppenheimer Maintains Outperform -> Outperform
2024-07-31 Barclays Maintains Overweight -> Overweight
2024-07-31 Wedbush Reiterate Outperform -> Outperform
2024-05-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-09 Wells Fargo Maintains Overweight -> Overweight
2024-05-08 Stifel Maintains Buy -> Buy
2024-05-08 Wedbush Reiterate Outperform -> Outperform
2024-05-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-25 Truist Securities Reiterate Buy -> Buy
2024-02-29 Barclays Maintains Overweight -> Overweight
2024-02-28 BMO Capital Maintains Outperform -> Outperform
2024-02-28 Oppenheimer Reiterate Outperform -> Outperform
2024-02-28 Wedbush Maintains Outperform -> Outperform
2024-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-15 Citigroup Downgrade Buy -> Neutral
2024-02-14 Citigroup Downgrade Buy -> Neutral
2024-02-01 Goldman Sachs Initiate Buy
2023-12-19 Wells Fargo Upgrade Equal-Weight -> Overweight
2023-12-06 Jefferies Upgrade Hold -> Buy
2023-11-20 Guggenheim Upgrade Neutral -> Buy
2023-11-13 Morgan Stanley Maintains Equal-Weight -> Equal-Weight